Firstly, although PNPLA3 I148M is the major genetic determinant of NAFLD-HCC, no other rare loss-of-function mutations were identified in this gene among the affected patients. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.